Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases
Devon E. McMahonDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MassachusettsErin AmersonDepartment of Dermatology, University of California San Francisco, San Francisco, CaliforniaMisha RosenbachDepartment of Dermatology, University of Pennsylvania, Philadelphia, PennsylvaniaJules B. LipoffDepartment of Dermatology, University of Pennsylvania, Philadelphia, PennsylvaniaDanna MoustafaMassachusetts General HospitalAnisha TyagiDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MassachusettsSeemal R. DesaiThe University of Texas Southwestern Medical Center, Dallas, Texas; Innovative Dermatology, Plano, TexasLars E. FrenchDepartment of Dermatology, University Hospital, Munich University of Ludwig Maximilian, Munich, Germany; Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FloridaHenry W. LimDepartment of Dermatology, Henry Ford Health System, Detroit, MichiganB.H. ThiersDepartment of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, South CarolinaGeorge J. HruzaDepartment of Dermatology, St. Louis University, St. Louis, MissouriKimberly G. BlumenthalDivision of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MassachusettsLindy P. FoxDepartment of Dermatology, University of California San Francisco, San Francisco, CaliforniaEsther E. FreemanDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Medical Practice Evaluation Center, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: [email protected]
2021en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba